Show simple item record

dc.contributor.authorGales, Ana C. [UNIFESP]
dc.contributor.authorJones, R. N.
dc.contributor.authorGordon, K. A.
dc.contributor.authorSader, Helio S. [UNIFESP]
dc.contributor.authorWilke, W. W.
dc.contributor.authorBeach, M. L.
dc.contributor.authorPfaller, M. A.
dc.contributor.authorDoern, G. V.
dc.contributor.authorSENTRY Study Grp Latin Amer
dc.date.accessioned2016-01-24T12:31:01Z
dc.date.available2016-01-24T12:31:01Z
dc.date.issued2000-03-01
dc.identifierhttp://dx.doi.org/10.1093/jac/45.3.295
dc.identifier.citationJournal of Antimicrobial Chemotherapy. Oxford: Oxford Univ Press, v. 45, n. 3, p. 295-303, 2000.
dc.identifier.issn0305-7453
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/26254
dc.description.abstractThe potency and spectrum of various antimicrobial agents tested against 434 bacterial isolates causing urinary tract infection (UTI) in hospitalized patients in Latin America were evaluated. the genotypes of the extended-spectrum beta-lactamase-producing and selected multi-resistant isolates were also evaluated by molecular typing techniques. Escherichia coli (60.4%) was the most common aetiological agent causing UTI, followed by Klebsiella spp. (11.2%) and Pseudomonas aeruginosa (8.3%). in contrast, Enterococcus spp. isolates caused only 2.3% of UTIs. Fewer than 50% of E. coli isolates were susceptible to broad-spectrum penicillins. the resistance rates to ciprofloxacin and the new quinolones were also high among these isolates. the molecular characterization of ciprofloxacin-resistant E coli showed that most of them have a double mutation in the gyrA gene associated with a single mutation in the parC gene. the Klebsiella pneumoniae isolates studied demonstrated high resistance rates to beta-lactam drugs, including broad-spectrum cephalosporins. the carbapenems were the compounds with the highest susceptibility rate among these isolates (100.0% susceptible) followed by cefepime (91.7% susceptible). Meropenem, imipenem and cefepime were also the most active drugs against Enterobacter spp. Among P. aeruginosa isolates, meropenem (MIC50, 2 mg/L) was the most active compound, followed by imipenem (MIC50, 4 mg/L), cefepime (MIC50, 8 mg/L) end ceftazidime (MIC50, 16 mg/L). the results presented in this report confirm that bacterial resistance continues to be a great problem in Latin American medical institutions.en
dc.format.extent295-303
dc.language.isoeng
dc.publisherOxford Univ Press
dc.relation.ispartofJournal of Antimicrobial Chemotherapy
dc.rightsAcesso aberto
dc.titleActivity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998)en
dc.typeArtigo
dc.rights.licensehttp://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html
dc.contributor.institutionUniv Iowa
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationUniv Iowa, Coll Med, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
dc.description.affiliationUniversidade Federal de São Paulo, Lab Especial Microbiol, Div Infect Dis, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Lab Especial Microbiol, Div Infect Dis, São Paulo, Brazil
dc.identifier.doi10.1093/jac/45.3.295
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000086244100005


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record